These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1287888)

  • 21. [Significance of eicosanoids for arteriosclerosis and the effect of lipoproteins on prostanoid formation].
    Mest HJ; Beitz J
    Z Gesamte Inn Med; 1986 Feb; 41(4):94-8. PubMed ID: 3518258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exogenous L-arginine and HDL can alter LDL and ox-LDL-mediated platelet activation: using platelet P-selectin receptor numbers.
    Sener A; Enc E; Ozsavci D; Vanizor-Kural B; Yanikkaya-Demirel G; Oba R; Uras F; Demir M
    Clin Appl Thromb Hemost; 2011; 17(6):E79-86. PubMed ID: 21078607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of platelet functions by low density lipoproteins.
    Surya II; Gorter G; Mommersteeg M; Akkerman JW
    Biochim Biophys Acta; 1992 Nov; 1165(1):19-26. PubMed ID: 1420343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activated platelets contribute to oxidized low-density lipoproteins and dysfunctional high-density lipoproteins through a phospholipase A2-dependent mechanism.
    Blache D; Gautier T; Tietge UJ; Lagrost L
    FASEB J; 2012 Feb; 26(2):927-37. PubMed ID: 22042222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aggregation of gel-filtered guinea-pig platelets by lipoproteins.
    Fujitani B; Tsuboi T; Yoshida K; Shimizu M
    Thromb Haemost; 1979 Apr; 41(2):416-24. PubMed ID: 224521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet activation by oxidatively modified low density lipoproteins.
    Ardlie NG; Selley ML; Simons LA
    Atherosclerosis; 1989 Apr; 76(2-3):117-24. PubMed ID: 2730708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Amplification and inhibition of platelet function by serum lipoproteins].
    Higashihara M
    Nihon Rinsho; 1992 Feb; 50(2):282-6. PubMed ID: 1613982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysine modification of LDL or lipoprotein(a) by 4-hydroxynonenal or malondialdehyde decreases platelet serotonin secretion without affecting platelet aggregability and eicosanoid formation.
    Malle E; Ibovnik A; Leis HJ; Kostner GM; Verhallen PF; Sattler W
    Arterioscler Thromb Vasc Biol; 1995 Mar; 15(3):377-84. PubMed ID: 7749848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid activation of human platelets by low concentrations of low-density lipoprotein via phosphatidylinositol cycle.
    Knorr M; Locher R; Vogt E; Vetter W; Block LH; Ferracin F; Lefkovits H; Pletscher A
    Eur J Biochem; 1988 Mar; 172(3):753-9. PubMed ID: 3350022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet interaction with high and low density lipoproteins.
    Aviram M; Brook JG
    Atherosclerosis; 1983 Mar; 46(3):259-68. PubMed ID: 6847742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of plasma lipoproteins with human platelets.
    Curtiss LK; Plow EF
    Blood; 1984 Aug; 64(2):365-74. PubMed ID: 6331546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoproteins and the inhibitory effect of human endothelial cells on platelet function.
    Nordøy A; Svensson B; Wiebe D; Hoak JC
    Circ Res; 1978 Oct; 43(4):527-34. PubMed ID: 210972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the effect of plasma lipoproteins on platelet function in vitro.
    Aviram M; Brook JG
    Haemostasis; 1983; 13(6):344-50. PubMed ID: 6421681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormalities in platelets and vascular endothelial cells induced by glycated lipoproteins.
    Takeda H; Yano T; Kishikawa H; Miyata T; Shinohara M; Yamaguchi E; Kobori S; Fan JL; Tokunaga O; Shichiri M
    Intern Med; 1992 Jun; 31(6):746-51. PubMed ID: 1392175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transfer of phosphatidylcholine, phosphatidylethanolamine and sphingomyelin from low- and high-density lipoprotein to human platelets.
    Engelmann B; Kögl C; Kulschar R; Schaipp B
    Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):781-9. PubMed ID: 8645158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transfer of very low density lipoprotein-associated phospholipids to activated human platelets.
    Ibrahim S; Djimet-Baboun A; Pruneta-Deloche V; Calzada C; Lagarde M; Ponsin G
    J Lipid Res; 2006 Feb; 47(2):341-8. PubMed ID: 16293890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal by high-density lipoprotein of the effect of oxidized low-density lipoprotein on nitric oxide synthase protein expression in human platelets.
    Mehta JL; Chen LY
    J Lab Clin Med; 1996 Mar; 127(3):287-95. PubMed ID: 9273362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arachidonic acid of platelet phospholipids is decreased after extracorporeal removal of plasma low density lipoproteins in patients with familial hypercholesterolemia.
    Bräutigam R; Bräutigam C; Lorenz R; Richter WO; Engelmann B
    Atherosclerosis; 1997 May; 131(1):97-106. PubMed ID: 9180250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced arachidonic acid and calcium metabolism in cholesteryl sulfate-enriched rat platelets.
    Blache D
    J Lipid Mediat Cell Signal; 1996 Mar; 13(2):127-38. PubMed ID: 8925194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-density lipoproteins inhibit the Na+/H+ antiport in human platelets. A novel mechanism enhancing platelet activity in hypercholesterolemia.
    Nofer JR; Tepel M; Kehrel B; Wierwille S; Walter M; Seedorf U; Zidek W; Assmann G
    Circulation; 1997 Mar; 95(6):1370-7. PubMed ID: 9118502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.